Actuate Therapeutics Competitors and Similar CompaniesClear all

Actuate Therapeutics's competitors and similar companies include Immunovative Therapies, Corvus Pharmaceuticals, GlycoMimetics and Karo Pharma.
Actuate Therapeutics
Actuate Therapeutics
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.
Immunovative Therapies
Immunovative Therapies
Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.
Corvus Pharmaceuticals
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
GlycoMimetics
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Karo Pharma
Karo Pharma
Karo Pharma is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
Founding Date
Founding Date
2015
Founding Date
2004
Founding Date
2014
Founding Date
2003
Founding Date
1987
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Fort Worth, US HQ
Dublin, IE
Locations
Jerusalem, IL HQ
Locations
Burlingame, US HQ
Locations
Rockville, US HQ
Locations
Stockholm, SE HQ
Stockholm, SE
Employees
Employees
9
Employees
8
Employees
4911% decrease
Employees
5025% increase
Employees
225
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
132 m
Valuation ($)
17.2 m
Valuation ($)
1.3 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$10k (FY, 2023)
Revenue (est.)
kr3b (FY, 2021)
Net income
Net income
N/A
Net income
N/A
Net income
($27m) (FY, 2023)
Net income
($36.9m) (FY, 2023)
Net income
(kr17m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 31.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 101.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Immunovative Therapies
HQ
Jerusalem, IL
Employees
8

Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.

View company
Corvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

View company
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

View company
Karo Pharma
HQ
Stockholm, SE
Employees
225

Karo Pharma is a healthcare company, which develops and markets products for pharmacies and the health care sectors.

View company